Dear Heart Team Member,
Aortic Stenosis is a ticking time bomb and many patients may die while waiting for AVR¹ with 40% of patients on a waiting list requiring an unplanned hospital admission in approximately a four month period².
In the current context of the treatment for patients with aortic stenosis, Edwards Lifesciences would like to help contribute to the Heart Team Community by facilitating a webinar on future considerations for aortic stenosis patients for optimal treatment with minimal hospital footprint.
The Webinar will be entitled “The Future of TAVI in the UK” and will feature talks from Prof. Nick Curzen on the BCIS vision for the future and Dr. Dan Blackman on the UK Valve For Life mission. The webinar will be chaired by Prof. Philip MacCarthy and live Q&A session panel discussion including Prof. Neil Ruparelia, Hammersmith Hospital, London, Mr. Wil Woan, Heart Valve Voice as well as Prof. Nick Curzen and Dr. Dan Blackman.
If you are interested in this event, please register below. Following registration, you will receive confirmation including practical information. This webinar will be conducted on Microsoft Teams, no other software will be required.
A significant part of the webinar agenda will be dedicated to a Q&A session and therefore, we would encourage you to submit any questions for this event here. However, questions can be asked during the live event.
In case you cannot attend this webinar live, please register to ensure you receive video recordings following the event.
We hope that this educational format will be of interest and value to you and we wish you good health and safety in this unprecedented time.
Business Unit Manager UK THV
Content goes here
Prof. Nick Curzen,
BCIS President, Southampton University Hospital
Dr. Dan Blackman,
EAPCI Valve For Life UK Lead, Leeds Teaching Hospitals NHS Trust
Prof. Neil Ruparelia,
Hammersmith Hospital, London
Prof. Philip MacCarthy,
King College Hospital, London
Mr. Wil Woan,
Heart Valve Voice